High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.8M
$3,772,798
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-06 | $853,993x12 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Sell to CoverΔOwn -11.3%
|
2026-03-02 | $505,389 | S | Form 4 |
|
MDGL
M
MADRIGAL PHARMACEUTICALS, INC.
Dier Mardi
• CFO
Equity Compensation
2025-12-02
$1,050,052Largex2
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Equity Compensation
|
2025-12-02 | $1,050,052Largex2 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $2,413,416Largex15 | S | Form 4 |